GI issues such as bloating, gas, and constipation Research suggests that people assigned female at birth who have two or three gastrointestinal symptomsconstipation, bloating, and gas, for exampleare three times more likely to experience back pain
A large observational study published in Nature Communications (Wang et al., 2024) followed 83,825 patients with obesity and found that GLP-1 receptor agonists, including semaglutide, were associated with a substantially lower risk of alcohol use disorder (AUD) incidence and recurrence
This section will break down these factors to help you make an informed decision
Disclaimer: Individual results may vary, and no guarantee is provided
Proper handling is essential, as emphasized in storage guidelines for GLP-1 receptor agonists
Acting on receptors in the brain ensures that semaglutide GLP-1 will suppress a persons appetite, and give feelings of fullness, as well as make people feel full for longer periods of time by slowing down the speed at that food leaves the stomach